Stephen Uden
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Stephen Uden is the founder of Rallybio LLC, founded in 2018, holding the titles of President, Chief Executive Officer & Director.
Dr. Uden is the founder of Rallybio Corp., founded in 2018, holding the titles of President, Chief Executive Officer & Director since 2023.
Former jobs include Head-Research & Development at Neurogen Corp.
and Senior Vice President-Research at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
Education includes an undergraduate degree from the University of London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RALLYBIO CORPORATION 1,73 % | 19.12.2025 | 91.920 ( 1,73 % ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RALLYBIO CORPORATION | Gründer | 01.01.2018 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Gründer | 01.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2017 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Technik-/Wissenschafts-/F&E-Leiter | 14.09.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen